Low dose CAPE treatment in a CAIA model of Inflammatory Arthritis

Bonnie Williams, Helen Tsangari, Melissa Cantley, Victor Marino, Jiake Xu, Egon Perilli, A. Kencana Dharmapatni, Tania Crotti

Research output: Contribution to conferenceAbstractpeer-review

Abstract

Rheumatoid arthritis is a chronic inflammatory disorder resulting in bone and
cartilage destruction. Bone loss has been attributed to the relative increase in the
number and activity of bone-resorbing osteoclasts and the activation of NF-kappaB..
Caffeic acid phenethyl ester (CAPE) is a natural bioactive compound from the
propolis of honeybee hives, which inhibits NFkappa B activity (Ang J Cell Physiol
2009) and has anti-inflammatory and immunomodulatory properties. We have shown
inhibition of bone resorption with low doses of CAPE (1mg/kg/day) in a wear particle
induced calvarial model of osteolysis (Zawawi Cal Tiss Int 2015).
Original languageEnglish
Pages487
Number of pages1
Publication statusPublished - 17 Dec 2015
EventAmerican Society for Bone and Mineral Research (ASBMR) Annual Meeting - Seattle, United States
Duration: 9 Oct 201512 Oct 2015
https://www.asbmr.org/education/abstracts

Conference

ConferenceAmerican Society for Bone and Mineral Research (ASBMR) Annual Meeting
Abbreviated titleASBMR 2015
Country/TerritoryUnited States
CitySeattle
Period9/10/1512/10/15
Internet address

Keywords

  • micro-CT
  • inflammatory arthritis
  • rheumatoid arthritis

Fingerprint

Dive into the research topics of 'Low dose CAPE treatment in a CAIA model of Inflammatory Arthritis'. Together they form a unique fingerprint.

Cite this